Exploratory analysis of postprogression and patient-centered outcomes in ARIEL3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
Name:
A1.2.full.pdf
Size:
574.5Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract
Authors
Coleman, ROza, AM
Lorusso, D
Aghajanian, C
Oaknin, A
Dean, A
Colombo, N
Weberpals, JI
Clamp, Andrew R
Scambia, G
Leary, A
Holloway, RW
Gancedo, MA
Fong, PC
Goh, JC
O'Malley, DM
Goble, S
Cameron, T
Bedel, J
Ledermann, JA
Affiliation
The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston- TX, USAIssue Date
2019
Metadata
Show full item recordCitation
Coleman R, Oza A, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Exploratory analysis of postprogression and patient-centered outcomes in ARIEL3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma. International Journal of Gynecological Cancer. 2019;29:A1-2.Journal
International Journal of Gynecological CancerDOI
10.1136/ijgc-2019-IGCS.2Additional Links
https://dx.doi.org/10.1136/ijgc-2019-IGCS.2Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/ijgc-2019-IGCS.2